Consistently, RAD21 and SMC1A/SMC3/PDS5B mutations represented a significantly greater proportion of cohesin-mutant AML than MDS as compared to STAG2 mutations (Fig. 1C). This evidence concerns the gene SMC1A and myelodysplastic syndrome.